Syros pharmaceuticals merger
WebJul 5, 2024 · Concurrent with the merger, Syros announced an oversubscribed $130 million private investment in public equity (PIPE) financing at a price per unit of $0.94. New and … WebSep 15, 2024 · Following the closing of the Merger, the combined company will trade on The Nasdaq Global Select Market under the ticker symbol “SYRS,” and will be led by Syros’ …
Syros pharmaceuticals merger
Did you know?
WebKEY WINS: Steered the strategic and operational integration of Tyme Inc. into Syros Pharmaceuticals following an acquisition. Now driving business for an artificial intelligence-powered... WebAt Syros, we have identified cancer patients with aberrant expression of genes that can be targeted with new therapies. We are focused on applying this approach to developing …
WebSep 16, 2024 · CAMBRIDGE, Mass., September 16, 2024 -- ( BUSINESS WIRE )--Syros Pharmaceuticals, Inc. (NASDAQ:SYRS), a leader in the development of medicines that … WebSyros Pharmaceuticals, Inc. 35 CambridgePark Drive, 4th Floor . Cambridge, Massachusetts 02140 (617) 744-1340 (Name, Address, Including Zip Code, and Telephone Number, Including Area Code, of Agent for Service) Copies to: Nancy Simonian, M.D. President and Chief Executive Officer.
WebSep 20, 2024 · Syros Pharmaceuticals has recently acquired its peer Tyme Technologies. The sole purpose of the merger was to acquire TYME's cash balance. Concurrently with …
WebJul 5, 2024 · Development stage biotech firms Syros Pharmaceuticals ( SYRS) and Tyme Technologies ( NASDAQ: TYME) announced on Tuesday that the companies entered into …
WebApr 15, 2024 · Syros Pharmaceuticals, Inc engages in the development of gene control therapies for cancer and diseases. Its product candidates include SY-1425, SY-2101, and SY-5609. The company was founded by... gmp fallowfield facebookWebTyme Technologies, Inc., a biotechnology company developing cancer metabolism-based therapies, completed its acquisition by merger with Syros Pharmaceuticals, Inc., a leader … gmpf annual reportWebApr 15, 2024 · Syros Pharmaceuticals has a 1-year low of $2.42 and a 1-year high of $12.93. Syros Pharmaceuticals (NASDAQ:SYRS – Get Rating) last released its quarterly earnings … bomberger she is sheWebApr 7, 2024 · Syros Pharmaceuticals is part of the Pharmaceuticals industry, and located in Massachusetts, United States. Syros Pharmaceuticals Location 35 Cambridge Park Dr, Cambridge, Massachusetts, 02140, United States Description Read More Industry Pharmaceuticals Healthcare Discover more about Syros Pharmaceuticals Beth Ann Work … gmp factsWebNov 14, 2024 · Closed Merger with TYME Technologies and Concurrent PIPE; Proceeds from Combined Transactions Augment Cash Balance, Ending Third Quarter with … bombergers ecommerceWebSep 15, 2024 · The new CUSIP number for Syros’ common stock following the reverse stock split is 87184Q206. On September 15, 2024, the holders of a majority of Syros’ … gmp fachauditorWebMar 2, 2024 · Syros Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Dec 12, 2024 Syros Pharmaceuticals Announces Publication in Blood Advances … gmpf annual report 2022